Vertex Pharmaceuticals earns steady profits from its cystic fibrosis medicines while expanding into new diseases. BioNTech ...
A single dose of Moderna’s mResvia RSV vaccine was 60.3% protective against documented respiratory syncytial virus (RSV) ...
Analysts have placed intismeran central to Moderna’s long-term growth beyond infectious diseases.
Data provided to health authorities have been falsely represented online.
Real-world analysis of more than 294,000 U.S. Veterans aged 65 and older found mNEXSPIKE was associated with a 35.9% lower risk of medically attended COVID-19 and a 47% lower risk of COVID-19-associat ...
Moderna Inc. is poised and ready for U.S. FDA approval of its autologous mRNA cancer vaccine, intismeran, and its hoped-for ...
The Unified Patent Court has ruled that Pfizer and BioNTech's COVID-19 vaccine infringes GlaxoSmithKline's RNA patent, leaving European sales of the two companies' blockbuster Comirnaty jab hanging by ...